EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 364 filers reported holding EXELIXIS INC in Q1 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,600 | -3.9% | 160,215 | +1.5% | 0.02% | -6.2% |
| Q1 2024 | $3,746 | +8.5% | 157,850 | +9.7% | 0.02% | -5.9% |
| Q4 2023 | $3,453 | +8.7% | 143,950 | -1.0% | 0.02% | 0.0% |
| Q3 2023 | $3,176 | +14.9% | 145,343 | +0.5% | 0.02% | +21.4% |
| Q2 2023 | $2,763 | +1.8% | 144,605 | +3.4% | 0.01% | -6.7% |
| Q1 2023 | $2,714 | +23.4% | 139,825 | +1.9% | 0.02% | +15.4% |
| Q4 2022 | $2,200 | -99.9% | 137,155 | +1.3% | 0.01% | -7.1% |
| Q3 2022 | $2,123,000 | -27.7% | 135,405 | -4.0% | 0.01% | -26.3% |
| Q2 2022 | $2,936,000 | +13.6% | 141,012 | +23.7% | 0.02% | +35.7% |
| Q1 2022 | $2,585,000 | +26.0% | 114,029 | +1.6% | 0.01% | +27.3% |
| Q4 2021 | $2,051,000 | -13.0% | 112,224 | +0.7% | 0.01% | -21.4% |
| Q3 2021 | $2,357,000 | +20.1% | 111,484 | +3.5% | 0.01% | +27.3% |
| Q2 2021 | $1,963,000 | -22.9% | 107,725 | -4.4% | 0.01% | -31.2% |
| Q1 2021 | $2,547,000 | +12.3% | 112,735 | -0.2% | 0.02% | +6.7% |
| Q4 2020 | $2,268,000 | -34.5% | 113,015 | -20.2% | 0.02% | -42.3% |
| Q3 2020 | $3,463,000 | -0.3% | 141,645 | -3.2% | 0.03% | -10.3% |
| Q2 2020 | $3,472,000 | +63.5% | 146,265 | +18.7% | 0.03% | +52.6% |
| Q1 2020 | $2,123,000 | +67.2% | 123,260 | +71.1% | 0.02% | +72.7% |
| Q4 2019 | $1,270,000 | -5.6% | 72,050 | -5.3% | 0.01% | -8.3% |
| Q3 2019 | $1,346,000 | -59.6% | 76,090 | -51.2% | 0.01% | -40.0% |
| Q2 2019 | $3,332,000 | -19.8% | 155,930 | -10.6% | 0.02% | -25.9% |
| Q1 2019 | $4,153,000 | +5.6% | 174,490 | -12.8% | 0.03% | -6.9% |
| Q4 2018 | $3,934,000 | +8.5% | 200,019 | -2.3% | 0.03% | +26.1% |
| Q3 2018 | $3,626,000 | +154.1% | 204,643 | +208.6% | 0.02% | +53.3% |
| Q2 2018 | $1,427,000 | +137.0% | 66,304 | +143.8% | 0.02% | -6.2% |
| Q1 2018 | $602,000 | – | 27,193 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 11,275,871 | $254,722,000 | 71.55% |
| GREAT POINT PARTNERS LLC | 1,201,100 | $27,133,000 | 5.61% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 886,534 | $20,027,000 | 5.30% |
| Sargent Investment Group, LLC | 498,350 | $11,258,000 | 2.96% |
| CAPITAL MANAGEMENT CORP /VA | 311,660 | $7,040,000 | 1.57% |
| EULAV Asset Management | 2,460,000 | $55,571,000 | 1.49% |
| CM Management, LLC | 80,000 | $1,807,000 | 1.34% |
| Integral Health Asset Management, LLC | 200,000 | $4,518,000 | 1.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,750,000 | $242,843,000 | 1.21% |
| Sofinnova Investments, Inc. | 839,181 | $18,957,000 | 1.14% |